SPOTLIGHT: Florida AG checks out Amgen marketing

The Attorney General's office in Florida is looking into allegations of Enbrel-related marketing shenanigans at Amgen, but hasn't launched a formal investigation. The Senate Finance Committee and the New Jersey AG already are probing the allegations, made by two former sales reps in arbitration with the company. Report

Suggested Articles

With AbbVie's two most recent launches outperforming expectations, investors could be looking at a steal with an Allergan merger looming.

Investors are clamoring for a CVR created in the BMS-Celgene deal, but it will only pay off if the FDA approves three hot pipeline projects.

Muzammil Mansuri, Sanofi’s EVP of strategy and business development since February 2016, is retiring at the end of November.